Doctor Practice Financing – Click Here for 100 percent financing for doctors starting up a practice or acquiring one!

Call: 904-551-6090

As you decide to start this important personal process, you will be required to create a detailed business plan that will include all the required elements for the medical practice. This formulated business plan will be of use to us so that we can be able to assess your general operation. You will be pleased to know that as lenders we are dedicated to undertake a fair assessment process of your plan so that we can effectively provide for the required finances that will be sufficient to handle all the initial company processes. With the cash-flow project that will be reflected by your business plan, you will be set to obtain a reasonable amount to money for your medical practice.

Read The Interesting Snippets Below For Exciting Health-Care News!

Edwards heart valve system tops Medtronic version in small study

– http://www.reuters.com/healthNews

WASHINGTON (Reuters) – The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head study of the two, according to data from a small German trial presented at a major heart meeting on Sunday.

Continue Reading On http://www.reuters.com/healthNews »

Glaxo heart drug that failed trial shows potential benefit

– http://www.reuters.com/healthNews

WASHINGTON (Reuters) – A new type of heart drug being developed by GlaxoSmithKline, which failed the main goal of a Phase III study of patients with chronic but well-treated heart disease, showed signs of potential benefit, the trial’s co-leader said.

Continue Reading On http://www.reuters.com/healthNews »

AstraZeneca digs into new Cambridge home with MRC drug deal

– http://www.reuters.com/healthNews

CAMBRIDGE, England (Reuters) – AstraZeneca, which will complete its move to Cambridge by 2016, is already putting down roots in the ecosystem of the university city as it seeks to revitalize its drug research.

Continue Reading On http://www.reuters.com/healthNews »

Japan's Takeda, Dainippon get EU nod for schizophrenia drug

– http://www.reuters.com

TOKYO, March 31 (Reuters) – Takeda Pharmaceutical Co Ltd and Dainippon Sumitomo Pharma Co Ltd said on Monday the European Commission had given them marketing authorisation for Latuda, a once-a-day oral treatment for schizophrenia in adults.

Continue Reading On http://www.reuters.com »

Ancient rheumatism drug reduces recurring inflammation around heart

– http://www.reuters.com/healthNews

WASHINGTON (Reuters) – A drug that was used in the time of the pharaohs for rheumatism has proven highly effective in treating recurrent bouts of pericarditis, an inflammation of the sac surrounding the heart, according to findings of a new clinical trial.

Continue Reading On http://www.reuters.com/healthNews »

Obamacare hits milestone, but detours ahead for health law

– http://www.reuters.com/healthNews

WASHINGTON (Reuters) – President Barack Obama’s embattled U.S. healthcare law, having survived a rollout marred by technology failures, reaches a milestone on Monday with the end of its first enrollment wave, and with the administration likely to come close to its goal of signing up 7 million people in private health insurance.

Continue Reading On http://www.reuters.com/healthNews »